Search
Omeros Corp
OMERAdd to Watchlist
9.280USD
-0.130-1.38%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
538.83MMarket Cap
7.12P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Omeros Corp is 7.60, ranking 280 out of 387 in the Biotechnology & Medical Research industry. The average price target is 36.00, with a high of 45.00 and a low of 20.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
44.000
Target Price
+367.59%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Omeros Corp
OMER
4
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Omeros Corp's price target?
Analysts forecast that Omeros Corp's price target is USD 36.00, with the highest forecast at USD 45.00 and the lowest forecast at USD 20.00.
How have Omeros CorpOMER's recent earnings per share performed?
The market expectation was USD 0.78, while Omeros CorpOMER's earnings per share (EPS) for the previous quarter was USD 1.22. EPS for the next quarter is expected at USD 0.17.
What is the analyst rating for Omeros Corp?
Based on the ratings of Omeros Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.